Here, we analyzed the role of NFE2L3 in tumor development in vivo using a mouse model of colitis-associated CRC, based on the treatment with the carcinogen azoxymethane and the inflammation-inducing agent dextran sodium sulfate [8, 25]. This evidence concerns the gene NFE2L3 and colorectal carcinoma.